(Q48207291)

9 February 2018

title

Analysis of tumor control and toxicity in patients who have survived at least one year after radiosurgery for brain metastases. (English)

1 reference

9 February 2018

0 references

2

1 reference

9 February 2018

Douglas Kondziolka

5

object named as

Douglas Kondziolka

1 reference

9 February 2018

John M Varlotto

1

1 reference

9 February 2018

Ajay Niranjan

3

1 reference

9 February 2018

Ajay K Bhatnagar

4

1 reference

9 February 2018

L Dale Lunsford

6

1 reference

9 February 2018

language of work or name

English

0 references

publication date

1 October 2003

1 reference

9 February 2018

International Journal of Radiation Oncology Biology Physics

published in

1 reference

9 February 2018

volume

57

1 reference

9 February 2018

issue

2

1 reference

9 February 2018

page(s)

452-464

1 reference

9 February 2018

Stereotactic radiosurgery for the definitive, noninvasive treatment of brain metastases.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900568-6

7 January 2021

A randomized trial of surgery in the treatment of single metastases to the brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900568-6

7 January 2021

Stereotactic radiosurgery plus whole brain radiotherapy versus radiotherapy alone for patients with multiple brain metastases

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900568-6

7 January 2021

The choice of treatment of single brain metastasis should be based on extracranial tumor activity and age.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900568-6

7 January 2021

A randomized trial to assess the efficacy of surgery in addition to radiotherapy in patients with a single cerebral metastasis.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900568-6

7 January 2021

A multiinstitutional outcome and prognostic factor analysis of radiosurgery for resectable single brain metastasis.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900568-6

7 January 2021

The cost effectiveness of stereotactic radiosurgery versus surgical resection in the treatment of solitary metastatic brain tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900568-6

7 January 2021

Defining the role of radiosurgery in the management of brain metastases

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900568-6

7 January 2021

Gamma Knife surgery for cerebral metastases. Implications for survival based on 16 years experience.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900568-6

7 January 2021

Linear accelerator-based stereotaxic radiosurgery for brain metastases:the influence of number of lesions on survival.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900568-6

7 January 2021

Radiosurgery for brain metastases: relationship of dose and pattern of enhancement to local control.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900568-6

7 January 2021

Radiosurgery alone or in combination with whole-brain radiotherapy for brain metastases.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900568-6

7 January 2021

Patient selection criteria for the treatment of brain metastases with stereotactic radiosurgery.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900568-6

7 January 2021

Gamma knife radiosurgery for the treatment of brain metastases

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900568-6

7 January 2021

Stereotactic radiosurgery for brain metastases: results and prognostic factors

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900568-6

7 January 2021

A single institutional outcome analysis of Gamma Knife radiosurgery for single or multiple brain metastases.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900568-6

7 January 2021

Solitary brain metastases treated with the Leksell gamma knife: prognostic factors for patients

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900568-6

7 January 2021

Radiosurgery for brain metastases: the Tuebingen experience.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900568-6

7 January 2021

Development of a model to predict permanent symptomatic postradiosurgery injury for arteriovenous malformation patients. Arteriovenous Malformation Radiosurgery Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900568-6

7 January 2021

Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900568-6

7 January 2021

Chemotherapy of cerebral metastases from solid tumors.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900568-6

7 January 2021

Systemic chemotherapy of brain metastases from small-cell lung cancer: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900568-6

7 January 2021

Response of brain metastases from breast cancer to systemic chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900568-6

7 January 2021

Preoperative chemotherapy followed by concurrent chemoradiation therapy based on hyperfractionated accelerated radiotherapy and definitive surgery in locally advanced non-small-cell lung cancer: mature results of a phase II trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900568-6

7 January 2021

Reversible posterior leukoencephalopathy syndrome following CHOP chemotherapy for diffuse large B-cell lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900568-6

7 January 2021

Cisplatin-induced non-convulsive encephalopathy.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900568-6

7 January 2021

Multifocal leukoencephalopathy associated with 5-fluorouracil and levamisole adjuvant therapy for colon cancer. A report of two cases and review of the literature. The INTACC. Intergruppo Nazionale Terpia Adiuvante Colon Carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900568-6

7 January 2021

Cognitive effects of standard-dose chemotherapy in patients with cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900568-6

7 January 2021

Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900568-6

7 January 2021

Intracerebral metastases in solid-tumor patients: Natural history and results of treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900568-6

7 January 2021

The palliation of brain metastases: Final results of the first two studies by the radiation therapy oncology group

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900568-6

7 January 2021

A randomized phase III study of accelerated hyperfractionation versus standard in patients with unresected brain metastases: a report of the Radiation Therapy Oncology Group (RTOG) 9104.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900568-6

7 January 2021

Phases IB and II multidose trial of gadolinium texaphyrin, a radiation sensitizer detectable at MR imaging: preliminary results in brain metastases.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900568-6

7 January 2021

RSR13 plus cranial radiation therapy in patients with brain metastases: comparison with the Radiation Therapy Oncology Group Recursive Partitioning Analysis Brain Metastases Database

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900568-6

7 January 2021

Melatonin: from basic research to cancer treatment clinics

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900568-6

7 January 2021

Phase II randomized trial of temozolomide and concurrent radiotherapy in patients with brain metastases

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900568-6

7 January 2021

10.1016/S0360-3016(03)00568-6

Identifiers

DOI

1 reference

9 February 2018

release_b3tat7hrzvbfhmdihnoscurzj4

Fatcat ID

0 references

PubMed ID

12957257

1 reference

9 February 2018